Actively Recruiting
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Led by University Hospital, Brest · Updated on 2024-06-17
10
Participants Needed
1
Research Sites
191 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Impact of monocytes on Myeloproliferative Neoplasm hematopoietic stem cell growth and differentiation in vitro
CONDITIONS
Official Title
Exploring the Impact of Monocytes in Myeloproliferative Neoplasia (EMYNEM)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of MPN in the participating center
- Over 18 yo
You will not qualify if you...
- Not able to consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chu Brest
Brest, France, 29609
Actively Recruiting
Research Team
E
Eric LIPPERT
CONTACT
W
Wayne Corentin LAMBERT
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here